Sutimlimab suppresses SARS-CoV-2 mRNA vaccine-induced hemolytic crisis in a patient with cold agglutinin disease
This report suggests that appropriate sutimlimab administration can suppress SARS-CoV-2 mRNA vaccination-induced CAD exacerbation, and that it could be a preventive strategy to minimize hemolytic attacks in susceptible populations.PMID:38148014 | DOI:10.3960/jslrt.23040
Source: Journal of Clinical and Experimental Hematopathology : JCEH - Category: Hematology Authors: Hiroki Kobayashi Tomoki Ouchi Wataru Kitamura Shoji Asakura Tomofumi Yano Hiromasa Takeda Yoshiyuki Tokuda Tadashi Yoshino Yoshinobu Maeda Source Type: research
More News: Anemia | Autoimmune Disease | Coronavirus | Covid Vaccine | COVID-19 | Hematology | Respiratory Medicine | SARS | Vaccines